Cover Page
Cover Page - shares | 3 Months Ended | |
Mar. 31, 2023 | Aug. 09, 2023 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Mar. 31, 2023 | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2023 | |
Current Fiscal Year End Date | --12-31 | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity Registrant Name | Four Leaf Acquisition Corporation | |
Entity Central Index Key | 0001936255 | |
Entity File Number | 001-41646 | |
Entity Tax Identification Number | 88-1178935 | |
Entity Interactive Data Current | Yes | |
Entity Current Reporting Status | No | |
Entity Shell Company | true | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Incorporation, State or Country Code | DE | |
Entity Address, Address Line One | 4546 El Camino Real B10 #715 | |
Entity Address, City or Town | Los Altos | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 94022 | |
City Area Code | 650 | |
Local Phone Number | 720-5626 | |
Capital Units [Member] | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Units, each consisting of one share of Class A common stock and one redeemable Warrant | |
Security Exchange Name | NASDAQ | |
Trading Symbol | FORLU | |
Common Class A [Member] | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Class A common stock, par value $0.0001 per share | |
Security Exchange Name | NASDAQ | |
Trading Symbol | FORL | |
Entity Common Stock, Shares Outstanding | 5,475,210 | |
Common Class B [Member] | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 1,355,250 | |
Warrant [Member] | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Warrants, each exercisable for one share of Class A common stock for $11.50 per share | |
Security Exchange Name | NASDAQ | |
Trading Symbol | FORLW |
Condensed Balance Sheets
Condensed Balance Sheets - USD ($) | Mar. 31, 2023 | Dec. 31, 2022 | |
Current assets | |||
Cash | $ 285,320 | $ 1,280 | |
Due from related party | 27,820 | 2,820 | |
Prepaid expenses | 7,500 | 7,500 | |
Total current assets | 320,640 | 11,600 | |
Other assets | |||
Marketable securities held in trust account | 55,898,120 | 0 | |
Deferred offering costs | 0 | 705,130 | |
Total assets | 56,218,760 | 716,730 | |
Current liabilities | |||
Accrued offering costs | 214,412 | 386,536 | |
Accounts payable | 46,436 | 0 | |
Over-allotment liability | 173,764 | 0 | |
Promissory note - related party | 0 | 311,500 | |
Income taxes payable | 7,039 | 0 | |
Total current liabilities | 441,651 | 698,036 | |
Deferred underwriting fee payable | 1,897,350 | 0 | |
Total liabilities | 2,339,001 | 698,036 | |
Commitments and contingencies (Note 6) | |||
Class A common stock, $0.0001 par value; 26,000,000 shares authorized; 5,421,000 shares subject to possible redemption | 49,242,796 | 0 | |
Stockholders' equity | |||
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding | 0 | 0 | |
Additional paid-in capital | 4,685,898 | 24,850 | |
Accumulated deficit | (49,090) | (6,306) | |
Total stockholders' equity | 4,636,963 | 18,694 | |
Total liabilities, common stock subject to possible redemption, and stockholders' equity | 56,218,760 | 716,730 | |
Common Class A [Member] | |||
Current liabilities | |||
Class A common stock, $0.0001 par value; 26,000,000 shares authorized; 5,421,000 shares subject to possible redemption | 49,242,796 | ||
Stockholders' equity | |||
Common stock | 5 | 0 | |
Common Class B [Member] | |||
Stockholders' equity | |||
Common stock | [1] | $ 150 | $ 150 |
[1]Includes up to 139,750 shares of Class B common stock, $0.0001 pav value (“Class B common stock”) subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 5 and 7). On March 16, 2023, the Sponsor surrendered 373,750 founder shares, for no consideration, resulting in the Sponsor and directors continuing to hold 1,495,000 shares of Class B common stock. All share amounts have been adjusted to reflect the share surrender. |
Condensed Balance Sheets (Paren
Condensed Balance Sheets (Parenthetical) - $ / shares | Mar. 31, 2023 | Mar. 16, 2023 | Dec. 31, 2022 |
Preferred Stock, Par or Stated Value Per Share | $ 0.0001 | $ 0.0001 | |
Preferred stock, shares authorized | 5,000,000 | 5,000,000 | |
Preferred stock, shares issued | 0 | 0 | |
Preferred stock, shares outstanding | 0 | 0 | |
Common Class A [Member] | |||
Temporary equity, par or stated value per share | $ 0.0001 | $ 0.0001 | |
Temporary equity, shares authorized | 26,000,000 | 26,000,000 | |
Temporary equity, shares outstanding | 5,421,000 | 5,421,000 | |
Common stock, par or stated value per share | $ 0.0001 | $ 0.0001 | |
Common stock, shares authorized | 26,000,000 | 26,000,000 | |
Common stock, shares, issued | 54,210 | 0 | |
Common stock, shares, outstanding | 54,210 | 0 | |
Common Class B [Member] | |||
Common stock, par or stated value per share | $ 0.0001 | $ 0.0001 | |
Common stock, shares authorized | 4,000,000 | 4,000,000 | |
Common stock, shares, issued | 1,495,000 | 1,495,000 | |
Common stock, shares, outstanding | 1,495,000 | 1,495,000 | |
Common Class B [Member] | Sponsor [Member] | |||
Common stock, shares, outstanding | 1,495,000 | ||
Common stock subject to forfeiture | 195,000 | ||
Common Class B [Member] | Over-Allotment Option [Member] | Sponsor [Member] | Founder Shares [Member] | |||
Common stock, shares authorized | |||
Common stock, shares, outstanding | 1,495,000 | ||
Common stock , shares subject to forfeiture | 139,750 | ||
Common stock subject to forfeiture | 373,750 |
Condensed Statements of Operati
Condensed Statements of Operations - USD ($) | 1 Months Ended | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2023 | ||
Formation and operating costs | $ 3,381 | $ 58,384 | |
Loss from operations | (3,381) | (58,384) | |
Other income (expense): | |||
Dividend and interest income from Trust Account | 61,820 | ||
Change in fair value of over-allotment liability | (39,181) | ||
Loss before income taxes | (3,381) | (35,745) | |
Income tax provision | (7,039) | ||
Net loss | $ (3,381) | $ (42,784) | |
Class A common stock subject to possible redemption [Member] | |||
Other income (expense): | |||
Weighted average shares outstanding, basic | 5,421,000 | ||
Weighted average shares outstanding, diluted | 5,421,000 | ||
Basic net loss per share | $ (0.01) | ||
Diluted net loss per share | $ (0.01) | ||
Class A common stock [Member] | |||
Other income (expense): | |||
Weighted average shares outstanding, basic | 54,210 | ||
Weighted average shares outstanding, diluted | 54,210 | ||
Basic net loss per share | $ (0.01) | ||
Diluted net loss per share | $ (0.01) | ||
Class B common stock [Member] | |||
Other income (expense): | |||
Weighted average shares outstanding, basic | [1] | 1,309,208 | |
Weighted average shares outstanding, diluted | [1] | 1,309,208 | |
Basic net loss per share | $ (0.01) | ||
Diluted net loss per share | $ (0.01) | ||
[1]Excludes up to 139,750 shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 5 and 7). |
Condensed Statements of Opera_2
Condensed Statements of Operations (Parenthetical) - shares | Mar. 31, 2023 | Mar. 16, 2023 |
Common Class B [Member] | Over-Allotment Option [Member] | Sponsor [Member] | Founder Shares [Member] | ||
Common stock , shares subject to forfeiture | 139,750 |
Condensed Statements of Changes
Condensed Statements of Changes in Stockholders' Equity - USD ($) | Total | Private Placement Warrants [Member] | Public Warrants [Member] | Class A Common Stock Subject To Possible Redemption [Member] | Common Class A [Member] | Common Stock [Member] Common Class A [Member] | Common Stock [Member] Common Class B [Member] | Additional Paid-in Capital [Member] | Additional Paid-in Capital [Member] Private Placement Warrants [Member] | Additional Paid-in Capital [Member] Public Warrants [Member] | Accumulated Deficit [Member] | |
Temporary Equity, Beginning Balance (Shares) at Mar. 02, 2022 | 0 | |||||||||||
Temporary Equity, Beginning Balance at Mar. 02, 2022 | $ 0 | |||||||||||
Beginning Balance (Shares) at Mar. 02, 2022 | 0 | 0 | ||||||||||
Beginning Balance at Mar. 02, 2022 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | |||||||
Net loss | (3,381) | (3,381) | ||||||||||
Temporary Equity, Ending Balance (Shares) at Mar. 31, 2022 | 0 | |||||||||||
Temporary Equity, Ending Balance at Mar. 31, 2022 | $ 0 | |||||||||||
Ending Balance (Shares) at Mar. 31, 2022 | 0 | 0 | ||||||||||
Ending Balance at Mar. 31, 2022 | (3,381) | $ 0 | $ 0 | 0 | (3,381) | |||||||
Temporary Equity, Beginning Balance (Shares) at Dec. 31, 2022 | 0 | 5,421,000 | ||||||||||
Temporary Equity, Beginning Balance at Dec. 31, 2022 | 0 | $ 0 | ||||||||||
Beginning Balance (Shares) at Dec. 31, 2022 | 0 | 1,495,000 | [1] | |||||||||
Beginning Balance at Dec. 31, 2022 | 18,694 | $ 0 | $ 150 | 24,850 | (6,306) | |||||||
Issuance of warrants | $ 3,577,000 | $ 1,127,840 | $ 3,577,000 | $ 1,127,840 | ||||||||
Issuance of Class A common stock, net of issuance costs (Shares) | 5,421,000 | |||||||||||
Issuance of Class A common stock, net of issuance costs | $ 48,928,489 | |||||||||||
Issuance of representative shares (Shares) | 54,210 | |||||||||||
Issuance of representative shares | 270,520 | $ 5 | 270,515 | |||||||||
Accretion of Class A common stock to redemption value | (314,307) | $ 314,307 | $ (314,307) | (314,307) | ||||||||
Net loss | (42,784) | (42,784) | ||||||||||
Temporary Equity, Ending Balance (Shares) at Mar. 31, 2023 | 5,421,000 | 5,421,000 | ||||||||||
Temporary Equity, Ending Balance at Mar. 31, 2023 | 49,242,796 | $ 49,242,796 | $ 49,242,796 | |||||||||
Ending Balance (Shares) at Mar. 31, 2023 | 54,210 | 1,495,000 | [1] | |||||||||
Ending Balance at Mar. 31, 2023 | $ 4,636,963 | $ 5 | $ 150 | $ 4,685,898 | $ (49,090) | |||||||
Temporary Equity, Beginning Balance (Shares) at Mar. 16, 2023 | ||||||||||||
[1]Includes up to 139,750 shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 5 and 7). On March 16, 2023, the Sponsor surrendered 373,750 founder shares, for no consideration, resulting in the Sponsor and directors continuing to hold 1,495,000 shares of Class B common stock. All share amounts have been adjusted to reflect the share surrender. |
Condensed Statements of Chang_2
Condensed Statements of Changes in Stockholders' Equity (Parenthetical) - USD ($) | 3 Months Ended | |
Mar. 16, 2023 | Mar. 31, 2023 | |
Public Warrants [Member] | ||
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | $ 90,313 | |
Common Class A [Member] | ||
Common stock, shares, outstanding | 54,210 | |
Issuance costs of stock | $ 3,928,774 | |
Common Class B [Member] | ||
Common stock, shares, outstanding | 1,495,000 | |
Common Class B [Member] | Sponsor [Member] | ||
Common stock, shares, outstanding | 1,495,000 | |
Common stock subject to forfeiture | 195,000 | |
Common Class B [Member] | Over-Allotment Option [Member] | Sponsor [Member] | Founder Shares [Member] | ||
Common stock , shares subject to forfeiture | 139,750 | |
Common stock, shares, outstanding | 1,495,000 | |
Common stock subject to forfeiture | 373,750 |
Condensed Statements of Cash Fl
Condensed Statements of Cash Flows - USD ($) | 1 Months Ended | 3 Months Ended |
Mar. 31, 2022 | Mar. 31, 2023 | |
Cash Flows from Operating Activities: | ||
Net loss | $ (3,381) | $ (42,784) |
Adjustments to reconcile net loss to net cash used in operating activities | ||
Dividend and interest income from Trust Account | 0 | (61,820) |
Loss on change in fair value of over-allotment option | 39,181 | |
Changes in current assets and liabilities | ||
Accounts payable | 1,315 | 46,436 |
Income taxes payable | 0 | 7,039 |
Net cash used in operating activities | (2,066) | (11,948) |
Cash Flows from Investing Activities | ||
Investment of cash into Trust Account | 0 | (55,836,300) |
Net cash used in investing activities | 0 | (55,836,300) |
Cash Flows from Financing Activities: | ||
Proceeds from founder share prepayment | 25,000 | 0 |
Payment of deferred offering costs | 0 | 0 |
Due from related party | (2,820) | (25,000) |
Proceeds from promissory note | 84,000 | |
Repayment of promissory note | 0 | (395,500) |
Gross proceeds from issuance of public units | 0 | 54,210,000 |
Proceeds from issuance of Private Placement Warrants | 0 | 3,577,000 |
Payment of offering costs on public units | (16,228) | (1,318,212) |
Net cash provided by financing activities | 5,952 | 56,132,288 |
Net change in cash | 3,886 | 284,040 |
Cash - beginning of the period | 0 | 1,280 |
Cash - end of the period | 3,886 | 285,320 |
Non-cash investing and financing activities: | ||
Remeasurement of Class A common stock subject to possible redemption | 0 | 314,307 |
Deferred underwriting commissions | 0 | 1,897,350 |
Issuance of representative shares for services | 0 | 270,515 |
Offering costs included in accrued offering costs | $ 50,696 | $ 214,412 |
Organization and Description of
Organization and Description of Business | 3 Months Ended |
Mar. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Description of Business | NOTE 1 — ORGANIZATION AND DESCRIPTION OF BUSINESS Nature of Operations Four Leaf Acquisition Corporation (the “Company”) is a newly organized blank check company that was incorporated as a Delaware corporation on March 3, 2022 and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target . As of March 31, 2023, the Company had not commenced any operations. All activity for the period from March 3, 2022 (inception) through March 31, 2023 relates to the Company’s formation and the initial public offering (“IPO”) (as described below). The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate non-operating The Company has selected December 31 as its fiscal year end. The Company’s sponsor is ALWA Sponsor, LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s IPO was declared effective on March 16, 2023. On March 16, 2023, the Company consummated its IPO of units (“Units”). On March 17, 2023, the underwriters partially exercised their over-allotment option and purchased 221,000 additional Units. Each Unit consists of Class A common stock, c s Class A common stock per Unit, generating total gross proceeds of $54,210,000. Simultaneously with the consummation of the IPO and the sale of the Units, the Company consummated the private placement (“Private Placement”) of 3,576,900 warrants (“Private Placement Warrants”) to the Sponsor at a price of approximately per Placement Warrant, generating total proceeds of $ Transaction costs amounted to $4,019,087 consisting of $2,710,500 of underwriting commissions, $813,150 of which was paid out within three days of the IPO date, the Representative Shares (discussed in the below), and $1,038,067 of other offering costs. At the IPO date, cash of $974,028 was held outside of the Trust Account (as defined below) and is available for the payment of the Note (defined herein) when necessary (see Note 5), payment of accrued offering costs and for working capital purposes. In conjunction with this Public Offering, the Company issued to the underwriter shares of Class A common stock for nominal consideration (the “Representative Shares”). The fair value of the Representative Shares accounted for as compensation under Accounting Standards Codification (“ASC”) 718, “Compensation – Stock Compensation” (“ASC 718”) is included in the offering costs. The estimated fair value of the Representative Shares as of the IPO date totaled $ F per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), to be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its tax obligations, the proceeds from the IPO will not be released from the Trust Account until the earlier of: (a) the completion of the Company’s initial business combination, or (b) the redemption of the Company’s public shares if the Company is unable to complete its initial business combination in the prescribed time frame, as defined below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a business combination. There is no assurance that the Company will be able to complete a business combination successfully. The Company must complete one or more initial business combinations having an aggregate fair market value of at least In connection with any proposed initial business combination, the Company will either (1) seek stockholder approval of such initial business combination at a meeting called for such purpose at which stockholders may seek to convert their shares, regardless of whether they vote for or against the proposed business combination or do not vote at all, into their pro rata share of the aggregate amount then on deposit in the Trust Account (net of taxes payable), or (2) provide its stockholders with the opportunity to sell their shares to the Company by means of a tender offer (and thereby avoid the need for a stockholder vote) for an amount equal to their pro rata share of the aggregate amount then on deposit in the Trust Account (net of taxes payable), in each case subject to the limitations described herein. If the Company determines to engage in a tender offer, such tender offer will be structured so that each stockholder may tender all of his, her or its shares rather than a pro rata portion of his, her or its shares. The decision as to whether the Company will seek stockholder approval of a proposed business combination or will allow stockholders to sell their shares to the Company in a tender offer will be made by the Company, solely in the Company’s discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require us to seek stockholder approval. If the Company determines to allow stockholders to sell their shares to the Company in a tender offer, it will file tender offer documents with the U.S. Securities and Exchange Commission (“SEC”) which will contain substantially the same financial and other information about the initial business combination as is required under the SEC’s proxy rules. The Company will proceed with a business combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a business combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the business combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its second amended and restated certificate of incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC prior to completing a business combination. If, however, stockholder approval of the transactions is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public stockholder may elect to redeem their public shares irrespective of whether they vote for or against the proposed transaction. Notwithstanding the foregoing redemption rights, if the Company seeks stockholder approval of its initial business combination and the Company does not conduct redemptions in connection with its initial business combination pursuant to the tender offer rules, the Certificate of Incorporation will provide that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of % of the shares sold in the IPO (Excess Shares”). However, the Company’s stockholders will not be restricted to vote all of their shares (including Excess shares) for or against the initial business combination. Additionally, such stockholders will not receive redemption distributions with respect to the Excess Shares if the Company completes the initial business combination. The Company’s Sponsor, officers and directors (the “Initial Stockholders”) have agreed not to propose any amendment to the Certificate of Incorporation that would affect the Company’s public stockholders’ ability to convert or sell their shares to the Company in connection with a business combination as described herein or affect the substance or timing of the Company’s obligation to redeem from the closing of the IPO (the “Combination Period”) unless the Company provides its public stockholders with the opportunity to convert their shares of Class A common stock upon the approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest not previously released to the Company but net of franchise and income taxes payable, divided by the number of then outstanding public shares. If the Company is unable to complete an initial business combination within 12 months (or up to 18 months if the Company extends the period of time to consummate a business combination up to two times by an additional three months each time) from the closing of the IPO, or March 22, 2024 (or August 22, 2024), we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the shares of Class A common stock subject to possible redemption, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less any income or franchise tax obligations and up to $ of interest to pay dissolution expenses), divided by the number of then outstanding shares of Class A common stock, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. The Company’s Initial Stockholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to any Class B In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.30 per Public Share or (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriter of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Going Concern Consideration As of March 31, 2023, the Company had $285,320 in cash available for working capital needs. All remaining cash held in the Trust Account is generally unavailable for the Company’s use, prior to an initial business combination, and is restricted for use either in a business combination or to redeem of interest and dividends earned in the Trust Account are available to pay dissolution expenses, if necessary. The Company may also withdraw dividend and interest income earned in the Trust Account to pay income and franchise taxes The $285,320 held outside of the Trust Account as of March 31, 2023, may not be sufficient to allow the Company to operate for at least the next 12 months from the issuance of the financial statements, assuming that a business combination is not consummated during that time. The Company may need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. Additionally, the Company has until March 22, 2024 to consummate a business combination. It is uncertain that the Company will be able to consummate a business combination by this time. If a business combination is not consummated by this date and an extension is not requested by the Sponsor, there will be a mandatory liquidation and subsequent dissolution of the Company. These conditions raise substantial doubt about the Company’s ability to continue as a going concern, assuming a business combination is not consummated. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. The Company believes that the proceeds raised in the IPO and the funds potentially available from loans from the Sponsor or any of their affiliates will not be sufficient to allow the Company to meet the expenditures required for operating its business for at least the next 12 months from the issuance of the Company’s financial statements, assuming that a business combination is not consummated during that time. However, if the estimate of the costs of identifying a target business, undertaking in-depth Risks and Uncertainties Results of operations and the Company’s ability to complete an initial business combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond its control. The business could be impacted by, among other things, downturns in the financial markets or in economic conditions, inflation, and increases in interest rates. The Company cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact the Company’s business and ability to complete an initial business combination. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. Inflation Reduction Act of 2022 On August 16, 2022, the Inflation Reduction Act of 2022 (the “IRA”) was signed into federal law. The IRA provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a business combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a business combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the business combination, extension or otherwise, (ii) the structure of a business combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a business combination (or otherwise issued not in connection with a business combination but issued within the same taxable year of a business combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a business combination and in the Company’s ability to complete a business combination. |
Summary Of Significant Accounti
Summary Of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
Summary Of Significant Accounting Policies | NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q S-X The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto for the period from March 3, 2022 (inception) through December 31, 2022 included in the Company’s Form S-1/A Use of Estimates The preparation of the unaudited condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement. Significant assumptions include the fair value of the Company’s Public Warrants and Representative Shares, at their issuance dates, and the valuation of the over-allotment option provided to the underwriters. Actual results could differ from those estimates. Emerging Growth Company The Company is an “emerging growth company”, as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Deferred Offering Costs Deferred offering costs consist of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO and were charged to temporary equity, equity and/or expense upon the completion of the IPO. The fair value of the Representative Shares was accounted for as compensation under ASC 718, was included in the offering costs at the IPO date. Net Loss Per Share of Class A Common Stock The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share” (“ASC 260”). Net loss per share is computed by dividing net loss by the weighted average number of shares of Class A common stock outstanding during the period. The weighted average shares for the three months ended March 31, 2023 are reduced for the effect of the Class B common stock that are subject to forfeiture. The Company’s statements of operations include a presentation of net loss per share subject to redemption in a manner similar to the two-class 480-10-S99-3A, A reconciliation of net loss per share is as follows for the three months ended March 31, 2023: Class A Class A Class B Allocation of undistributable losses $ (34,186 ) $ (342 ) $ (8,256 ) Weighted average shares outstanding, basic and diluted 5,421,000 54,210 1,309,208 Basic and diluted net loss per share $ (0.01 ) $ (0.01 ) $ (0.01 ) For the period from March 3, 2022 (inception) through March 31, 2022, there were no shares that had been issued or were outstanding. Marketable Securities Held in Trust Account At March 31, 2023, the assets held in the Trust Account were substantially held in a treasury trust fund investing in U.S. Treasury Bills and U.S. Treasury Notes. These securities are presented on the unaudited condensed balance sheet at fair value at the end of each reporting period. Earnings on these securities are included in dividend and interest income in the accompanying unaudited condensed statements of operations and are automatically reinvested. The fair value for these securities is determined using quoted market prices in active markets. During the three months ended March 31, 2023, the Company did not withdraw any investment income from the Trust Account to pay its tax obligations. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying unaudited condensed balance sheet, primarily due to their short-term nature. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts. Share-Based Payment Arrangements The Company accounts for stock awards in accordance with ASC 718, which requires that all equity awards be accounted for at their fair value. Fair value is measured on the grant date and is equal to the underlying value of the stock. Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of grant for awards that vest immediately and have no future service condition. For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the Company’s initial estimates; previously recognized compensation cost is reversed if the service or performance conditions are not satisfied, and the award is forfeited. Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). Class A common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock sold as part of the Public Offering, features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption are classified as temporary equity and are accreted from the initial carrying amount to the redemption value over the period from the date of issuance to the earliest redemption date of the instrument on a straight-line basis. Subsequent to the IPO date, the accretion will also include the dividend and interest income earned in the Trust Account in excess of income and franchise taxes. The redemption value as of March 31, 2023 includes $100,000 that can be used to pay any dissolution expenses, should a dissolution event occur. The redemption value of the Class A c s T A The reconciliation of Class A common stock subject to possible redemption as of March 31, 2023 is as follows: Gross proceeds from sale of Public Units $ 54,210,000 Less: Proceeds allocated to Public Warrants (1,218,153 ) Less: Proceeds allocated to underwriters’ over-allotment option (134,584 ) Less: Issuance costs allocated to Class A common stock subject to possible redemption (3,928,774 ) Accretion to redemption value 314,307 Class A common stock subject to possible redemption $ 49,242,796 Derivative Financial Instruments The Company issued warrants to its investors and accounts for warrant instruments as either equity-classified or liability-classified instruments based on an assessment of the specific terms of the warrants and applicable authoritative guidance in ASC 480 and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own stock and whether the holders of the warrants could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. At the IPO date, the Public Warrants (see Note 3) and Private Placement Warrants (see Note 4) were accounted for as equity instruments as they meet all of the requirements for equity classification under ASC 815 based on current expected terms, which are subject to change. The over-allotment option was deemed to be a freestanding financial instrument indexed to the contingently redeemable shares and was accounted for as a liability pursuant to ASC 480. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of March 31, 2023, the Company held Level 1 financial instruments, which are the Company’s marketable securities held in the Trust Account. The Company did not hold any Level 1 financial instruments as of December 31, 2022. The Company determined the fair value of the over-allotment liability on March 31, 2023 was $ , using the Bla ck March 31, Risk-free interest rate 4.77 % Expected option life 0.099 years Expected dividend yield 0 % Expected stock price volatility 5 % The change in fair value of the unexercised over-allotment option was $ for the three months ended March 31, 2023, which is included in change in fair value of over-allotment liability in the accompanying unaudited condensed statements of operations. The Representative Shares were valued using the fair value of the Class A c s 50 % probability of consummation of the business combination and a discount for lack of marketability. The Public Warrants were valued using a Monte Carlo simulation based on management’s assumption incorporating 50 % probability of completing a successful business combination. As such, these are considered to be non-recurring Level 3 fair value measurements. Due from Sponsor – Related Party The Due from Sponsor balances of $27,820 and $2,820 as of March 31, 2023 and December 31, 2022, respectively, includes $25,000 of an overpayment to the Sponsor in connection with the repayment of the Promissory Note and $2,820 related to expenses paid on behalf of the Sponsor. Income Taxes The Company adopted ASC 740, “Income Taxes”, at its inception. Under ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carryforwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax expense represents the change during the period in the deferred tax assets and deferred tax liabilities. The components of the deferred tax assets and liabilities are individually classified as current and non-current The Company recognizes the tax benefits of uncertain tax positions only when the positions are “more likely than not” to be sustained assuming examination by tax authorities and determined to be attributed to the Company. The determination of attribution, if any, applies for each jurisdiction where the Company is subject to income taxes on the basis of laws and regulations of the jurisdiction. The application of laws and regulations is subject to legal and factual interpretation, judgement, and uncertainty. Tax laws and regulations themselves are subject to change as a result of changes in fiscal policy, changes in legislation, the evolution of regulations, and court rulings. Therefore, the actual liability of the various jurisdictions may be materially different from management’s estimate. As of March 31, 2023 and December 31, 2022, the Company has no accrued interest or penalties related to uncertain tax positions. Recent Accounting Standards In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This guidance changes how entities account for convertible instruments and contracts in an entity’s own equity and simplifies the accounting for convertible instruments by removing certain separation models for convertible instruments. This guidance also modifies the guidance on diluted earnings per share calculations. This new guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023, but allows for early adoption. The Company is currently evaluating the potential impact that the adoption of this standard will have on its financial statements. Management does not believe that any additional recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements. |
Initial Public Offering
Initial Public Offering | 3 Months Ended |
Mar. 31, 2023 | |
Equity [Abstract] | |
Initial Public Offering | NOTE 3 — INITIAL PUBLIC OFFERING On March 16, 2023, the Company sold 5,200,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one Public Warrant. Each Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $ 45-day Units at the IPO price. On March 17, 2023, the underwriters exercised their option to purchase 221,000 additional Units for the total amount of $2,210,000. The remaining over-allotment option for |
Private Placement
Private Placement | 3 Months Ended |
Mar. 31, 2023 | |
Disclosure of Private Placement [Abstract] | |
Private Placement | NOTE 4 — PRIVATE PLACEMENT On March 16, 2023, in the private placement that occurred simultaneously with the IPO, the Sponsor purchased an aggregate of warrants (each a “Private Placement Warrant”) at a price of $ On March 17, 2023, the underwriters partially exercised their over-allotment option resulting in the Company issuing Private Placement Warrants, generating an additional $ Each Private Placement Warrant entitles the holder to purchase one share of Class A common stock, subject to adjustment. The proceeds from the Private Placement of the Private Placement Warrants funded the trust account, IPO issuance costs and will fund the future operations prior to the business combination. If the Company does not complete an initial business combination within the Combination Period, the remaining proceeds, after payments from the sale of the Private Placement Warrants, will be included in the liquidating distribution to the public stockholders and the Private Placement Warrants will be worthless (see Note 8). |
Related Party Transactions
Related Party Transactions | 3 Months Ended |
Mar. 31, 2023 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | NOTE 5 — RELATED PARTY TRANSACTIONS Founder Shares In May 2022, the Sponsor paid $25,000, or approximately $0.011 per share, to cover certain offering costs in consideration for 2,156,250 shares of Class B common stock, par value $0.0001 (the “Founder Shares” or “Class B c s Founder Shares to each of Rahul Mewawalla and Stephen Markscheid, each of which are members of the Company’s Board of Directors (Note 8). The awards will vest simultaneously with the closing of an initial business combination, provided the director has continuously served on the Company’s Board of Directors through the closing of such initial business combination. On March 16, 2023, the Sponsor forfeited an aggregate of of the Founder Shares are subject to forfeiture to the extent the over-allotment option (see Note 6) is not exercised in full by the underwriter. On March 17, 2023, upon the partial exercise their over-allotment option by the underwriters, the forfeiture lapsed Founder Shares. As a result of the partial over-allotment, at March 31, 2023, the Company had Founder Shares that are subject to forfeiture to the extent the remainder of the over-allotment option (Note 6) is not exercised by the underwriter. Following the expiration of the underwriters’ remaining over-allotment option on April 30, 2023, the remaining Private Placement On March 16, 2023, in the private placement that occurred simultaneously with the IPO, the Sponsor purchased an aggregate of 3,449,500 warrants (each a “Private Placement Warrant”) at a price of $1.00 per warrant, for an aggregate purchase price of $3,449,500. On March 17, 2023, the underwriters partially exercised their over-allotment option resulting in the Company issuing 127,400 Private Placement Warrants, generating an additional $127,500 in gross proceeds. Each Private Placement Warrant entitles the holder to purchase one share of Class A common stock, subject to adjustment. The proceeds from the Private Placement of the Private Placement Warrants funded the trust account, IPO issuance costs and will fund the future operations prior to the business combination. If the Company does not complete an initial business combination within the Combination Period, the remaining proceeds, after payments from the sale of the Private Placement Warrants, will be included in the liquidating distribution to the public stockholders and the Private Placement Warrants will be worthless (see Note 8). Due from Related Party As of March 31, 2023 and December 31, 2023, the Company recorded $27,820 and $2,820, respectively, for amounts that were owed to the Company by the Sponsor. Promissory Note — Related Party Prior to March of 2023, the Sponsor had agreed to loan the Company an aggregate of up to $400,000 to cover expenses related to the proposed Initial Public Offering pursuant to a promissory note (the “Note”). The Note was non-interest bearing and payable on the earlier of October 31, 2023, the consummation of the IPO or the abandonment of the IPO. In March of 2023, the Company amended the Note to allow for the borrowing of an additional $40,000 (up to $440,000 in total) as well as adjusted the terms of the Note to provide that repayment occur on the later of the IPO, or October 31, 2023. The Company accounted for this amendment to the Note as a troubled debt restructuring on a prospective basis, which did not have a material impact on the Company’s financial statements. On March 24, 2023, the Company repaid all amounts outstanding under the Note. Working Capital Loans In order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required, up to $2,000,000 (“Working Capital Loans”). If the Company completes a business combination, the Company will repay the Working Capital Loans. Up to $2,000,000 of such loans may be converted into warrants, at a price of $1.00 per warrant at the option of the lender, upon consummation of the Company’s initial business combination. In the event that a business combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans will either be repaid upon consummation of a business combination, without interest, or, at the lender’s discretion. As of March 31, 2023, the Company had no borrowings under the Working Capital Loans. Administrative Support Agreement On March 22, 2023, the Company entered into an administrative support agreement under which it will pay the Sponsor a total of $10,000 per month, up until the completion of the Company’s initial business combination or liquidation, for secretarial and administrative services. Upon completion of the initial business combination or the Company’s liquidation, the Company will cease paying these monthly fees. For the period from March 22, 2023 through March 31, 2023, the Company’s expenses related to the administrative support agreement were immaterial. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | NOTE 6 — COMMITMENTS AND CONTINGENCIES Registration Rights The holders of the Founder Shares, Private Placement Warrants, warrants that may be issued upon conversion of Working Capital Loans (see Note 5), any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans and Class A issuable upon conversion of the Founder Shares, are entitled to registration rights pursuant to a registration rights agreement signed at the effective date of the IPO, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A common stock). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial business combination and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act. The registration rights agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering securities. Underwriting Agreement At the IPO date, the Company granted the underwriter a 45-day option from the date of the IPO to purchase additional Units to cover over-allotments, if any, at the price paid by the underwriter in the IPO. On March 17, 2023, the underwriters partially exercised their over-allotment option and purchased Units. The remaining over-allotment option for The underwriter received a fee of $0.15 per unit, or $813,150 in the aggregate at the closing of the IPO. In addition, $ In addition, in conjunction with the IPO, the Company issued to the underwriter Representative Shares. The holders of the Representative Shares agreed (a) that they will not transfer, assign or sell any such shares without the Company’s prior consent until the completion of the initial business combination, (ii) to waive their redemption rights (or right to participate in any tender offer) with respect to such shares in connection with the completion of the initial business combination and (iii) to waive their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete the initial business combination within the Combination Period. The representative shares are deemed to be underwriters’ compensation by FINRA pursuant to FINRA Rule 5 110. |
Stockholders' Equity
Stockholders' Equity | 3 Months Ended |
Mar. 31, 2023 | |
Stockholders' Equity Note [Abstract] | |
Stockholders' Equity | NOTE 7 — STOCKHOLDERS’ EQUITY Preferred Stock — and with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s Board of Directors. As of March 31, 2023 and December 31, 2022 there were Class A c s Class B c s shares of Class B c s per share. Holders of the Class B c s As of March 31, 2023 and December 31, 2022, there were shares of Class B common stock issued and outstanding. Refer to Note 5 for further detail. Holders of Class A common stock and holders of Class B common stock vote together as a single class on all other matters submitted to a vote of the Company’s stockholders except as otherwise required by law. The Class B common stock will automatically convert into Class A common stock at the time of a business combination at a ratio such that the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, % of the sum of (i) the total number of shares of common stock issued and outstanding upon completion of the IPO, plus (ii) the total number of shares of one-to-one. Warrants — Private Placement Warrants (collectively, the “Warrants”) were outstanding. The Public and Private Placement Warrants were issued in the same form at the IPO date. Each Warrant entitles the holder to purchase As of December 31, 2022, there were no Warrants outstanding. In addition, if (x) the Company issues additional shares of Class A c s per share of Class A c s % of the total equity proceeds, and interest thereon, available for the funding of the initial business combination on the date of the consummation of the initial business combination (net of redemptions), and (z) the Market Value is below $ per share, then the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to % of the greater of the Market Value and the Newly Issued Price, and the $ per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to % of the greater of the Market Value and the Newly Issued Price. The Warrants will become exercisable 30 c s The Warrants will expire five years Once the Warrants become exercisable, the Company may redeem the outstanding Warrants: • in whole and not in part; • at a price of $ 0.01 • upon not less than 30 “30-day • if, and only if, the reported last sale price of the Class A common stock equals or exceeds $ 18.00 20 a 30 -trading day period commencing once the warrants become exercisable and ending three days before the Company sends the notice of redemption to the warrant holders. If the Company call the warrants for redemption as described above, the Company’s management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” In determining whether to require all holders to exercise their warrants on a “cashless basis,” the Company’s management will consider, among other factors, the cash position, the number of warrants that are outstanding and the dilutive effect on the Company’s stockholders of issuing the maximum number of shares of Class A common stock issuable upon the exercise of the warrants. In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of Class A common stock equal to the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” for this purpose shall mean the average reported last sale price of the Class A common stock for trading days ending on the third day prior to the date on which the notice of redemption is sent to the holders of warrants. |
Stock-Based Compensation
Stock-Based Compensation | 3 Months Ended |
Mar. 31, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Stock-Based Compensation | NOTE 8 — STOCK-BASED COMPENSATION Class B Common Stock Share Transfers In August 2022, the Sponsor transferred 25,000 shares of Class B c s s The fair value of the Founder Shares on the grant date was approximately $0.81 per share. The valuation performed by the Company determined the fair value of the shares on the date of grant by applying a discount based upon (a) the probability of a successful IPO, (b) the probability of a successful business combination, and (c) the lack of marketability of the Founder Shares. The aggregate grant date fair value of the awards amounted to approximately $40,500. Total unrecognized compensation expense related to unvested Founder Shares at March 31, 2023 amounted to approximately $40,500 and is expected to be recognized upon the Triggering Event. Representative Shares On March 16, 2023, in conjunction with the IPO, the Company issued to the underwriter shares of Class A c s On March 17, 2023, the underwriters partially exercised their over-allotment option. As a result of the partial over-allotment, the underwriter received an additional The fair value of the Representative Shares is accounted for as compensation under ASC 718 and is included in the offering costs. The fair value of the |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | NOTE 9 — INCOME TAXES The Company’s effective tax rate (“ETR”) is calculated quarterly based upon current assumptions relating to the Company’s known and estimable operating results and various tax-related for the three months ended March 31, 2023 was primarily due to the change in the valuation allowance (as a result of dividend and interest income earned on the Company’s Trust Account), the permanent difference arising from the loss on change in fair value of the over-allotment liability and ETR adjustment s |
Subsequent Events
Subsequent Events | 3 Months Ended |
Mar. 31, 2023 | |
Subsequent Events [Abstract] | |
Subsequent Events | NOTE 10 — SUBSEQUENT EVENTS The Company did not identify any subsequent events that require adjustment or disclosure in the unaudited condensed financial statements other than as discussed below: On April 28, 2023, the Company identified a payment of $54,300 was incorrectly made to an unauthorized payee as a result of a phishing attack. The Company’s management, at the direction of the board of directors, investigated the matter and concluded that the phishing attack is an isolated incident perpetrated by an external source. The Company, with the assistance of its bank, recovered the funds on June 29, 2023. On April 30, 2023, the remaining over-allotment Units expired. Following the expiration of the underwriters’ remaining over-allotment option on April 30, 2023, the remaining |
Summary Of Significant Accoun_2
Summary Of Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q S-X The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto for the period from March 3, 2022 (inception) through December 31, 2022 included in the Company’s Form S-1/A |
Use of Estimates | Use of Estimates The preparation of the unaudited condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement. Significant assumptions include the fair value of the Company’s Public Warrants and Representative Shares, at their issuance dates, and the valuation of the over-allotment option provided to the underwriters. Actual results could differ from those estimates. |
Emerging Growth Company | Emerging Growth Company The Company is an “emerging growth company”, as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging |
Deferred Offering Costs | Deferred Offering Costs Deferred offering costs consist of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO and were charged to temporary equity, equity and/or expense upon the completion of the IPO. The fair value of the Representative Shares was accounted for as compensation under ASC 718, was included in the offering costs at the IPO date. |
Net Loss Per Share of Class A Common Stock | Net Loss Per Share of Class A Common Stock The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share” (“ASC 260”). Net loss per share is computed by dividing net loss by the weighted average number of shares of Class A common stock outstanding during the period. The weighted average shares for the three months ended March 31, 2023 are reduced for the effect of the Class B common stock that are subject to forfeiture. The Company’s statements of operations include a presentation of net loss per share subject to redemption in a manner similar to the two-class 480-10-S99-3A, A reconciliation of net loss per share is as follows for the three months ended March 31, 2023: Class A Class A Class B Allocation of undistributable losses $ (34,186 ) $ (342 ) $ (8,256 ) Weighted average shares outstanding, basic and diluted 5,421,000 54,210 1,309,208 Basic and diluted net loss per share $ (0.01 ) $ (0.01 ) $ (0.01 ) For the period from March 3, 2022 (inception) through March 31, 2022, there were no shares that had been issued or were outstanding. |
Marketable Securities Held in Trust Account | Marketable Securities Held in Trust Account At March 31, 2023, the assets held in the Trust Account were substantially held in a treasury trust fund investing in U.S. Treasury Bills and U.S. Treasury Notes. These securities are presented on the unaudited condensed balance sheet at fair value at the end of each reporting period. Earnings on these securities are included in dividend and interest income in the accompanying unaudited condensed statements of operations and are automatically reinvested. The fair value for these securities is determined using quoted market prices in active markets. During the three months ended March 31, 2023, the Company did not withdraw any investment income from the Trust Account to pay its tax obligations. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying unaudited condensed balance sheet, primarily due to their short-term nature. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts. |
Share-Based Payment Arrangements | Share-Based Payment Arrangements The Company accounts for stock awards in accordance with ASC 718, which requires that all equity awards be accounted for at their fair value. Fair value is measured on the grant date and is equal to the underlying value of the stock. Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of grant for awards that vest immediately and have no future service condition. For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the Company’s initial estimates; previously recognized compensation cost is reversed if the service or performance conditions are not satisfied, and the award is forfeited. |
Class A Common Stock Subject to Possible Redemption | Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). Class A common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock sold as part of the Public Offering, features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption are classified as temporary equity and are accreted from the initial carrying amount to the redemption value over the period from the date of issuance to the earliest redemption date of the instrument on a straight-line basis. Subsequent to the IPO date, the accretion will also include the dividend and interest income earned in the Trust Account in excess of income and franchise taxes. The redemption value as of March 31, 2023 includes $100,000 that can be used to pay any dissolution expenses, should a dissolution event occur. The redemption value of the Class A c s T A The reconciliation of Class A common stock subject to possible redemption as of March 31, 2023 is as follows: Gross proceeds from sale of Public Units $ 54,210,000 Less: Proceeds allocated to Public Warrants (1,218,153 ) Less: Proceeds allocated to underwriters’ over-allotment option (134,584 ) Less: Issuance costs allocated to Class A common stock subject to possible redemption (3,928,774 ) Accretion to redemption value 314,307 Class A common stock subject to possible redemption $ 49,242,796 |
Derivative Financial Instruments | Derivative Financial Instruments The Company issued warrants to its investors and accounts for warrant instruments as either equity-classified or liability-classified instruments based on an assessment of the specific terms of the warrants and applicable authoritative guidance in ASC 480 and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own stock and whether the holders of the warrants could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. At the IPO date, the Public Warrants (see Note 3) and Private Placement Warrants (see Note 4) were accounted for as equity instruments as they meet all of the requirements for equity classification under ASC 815 based on current expected terms, which are subject to change. The over-allotment option was deemed to be a freestanding financial instrument indexed to the contingently redeemable shares and was accounted for as a liability pursuant to ASC 480. |
Fair Value Measurements | Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of March 31, 2023, the Company held Level 1 financial instruments, which are the Company’s marketable securities held in the Trust Account. The Company did not hold any Level 1 financial instruments as of December 31, 2022. The Company determined the fair value of the over-allotment liability on March 31, 2023 was $ , using the Bla ck March 31, Risk-free interest rate 4.77 % Expected option life 0.099 years Expected dividend yield 0 % Expected stock price volatility 5 % The change in fair value of the unexercised over-allotment option was $ for the three months ended March 31, 2023, which is included in change in fair value of over-allotment liability in the accompanying unaudited condensed statements of operations. The Representative Shares were valued using the fair value of the Class A c s 50 % probability of consummation of the business combination and a discount for lack of marketability. The Public Warrants were valued using a Monte Carlo simulation based on management’s assumption incorporating 50 % probability of completing a successful business combination. As such, these are considered to be non-recurring Level 3 fair value measurements. |
Due from Sponsor – Related Party | Due from Sponsor – Related Party The Due from Sponsor balances of $27,820 and $2,820 as of March 31, 2023 and December 31, 2022, respectively, includes $25,000 of an overpayment to the Sponsor in connection with the repayment of the Promissory Note and $2,820 related to expenses paid on behalf of the Sponsor. |
Income Taxes | Income Taxes The Company adopted ASC 740, “Income Taxes”, at its inception. Under ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carryforwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax expense represents the change during the period in the deferred tax assets and deferred tax liabilities. The components of the deferred tax assets and liabilities are individually classified as current and non-current The Company recognizes the tax benefits of uncertain tax positions only when the positions are “more likely than not” to be sustained assuming examination by tax authorities and determined to be attributed to the Company. The determination of attribution, if any, applies for each jurisdiction where the Company is subject to income taxes on the basis of laws and regulations of the jurisdiction. The application of laws and regulations is subject to legal and factual interpretation, judgement, and uncertainty. Tax laws and regulations themselves are subject to change as a result of changes in fiscal policy, changes in legislation, the evolution of regulations, and court rulings. Therefore, the actual liability of the various jurisdictions may be materially different from management’s estimate. As of March 31, 2023 and December 31, 2022, the Company has no accrued interest or penalties related to uncertain tax positions. |
Recent Accounting Standards | Recent Accounting Standards In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This guidance changes how entities account for convertible instruments and contracts in an entity’s own equity and simplifies the accounting for convertible instruments by removing certain separation models for convertible instruments. This guidance also modifies the guidance on diluted earnings per share calculations. This new guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023, but allows for early adoption. The Company is currently evaluating the potential impact that the adoption of this standard will have on its financial statements. Management does not believe that any additional recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements. |
Summary Of Significant Accoun_3
Summary Of Significant Accounting Policies (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
Schedule Of Stock By Class | A reconciliation of net loss per share is as follows for the three months ended March 31, 2023: Class A Class A Class B Allocation of undistributable losses $ (34,186 ) $ (342 ) $ (8,256 ) Weighted average shares outstanding, basic and diluted 5,421,000 54,210 1,309,208 Basic and diluted net loss per share $ (0.01 ) $ (0.01 ) $ (0.01 ) |
Schedule of Temporary Equity By Class Of Stock | The reconciliation of Class A common stock subject to possible redemption as of March 31, 2023 is as follows: Gross proceeds from sale of Public Units $ 54,210,000 Less: Proceeds allocated to Public Warrants (1,218,153 ) Less: Proceeds allocated to underwriters’ over-allotment option (134,584 ) Less: Issuance costs allocated to Class A common stock subject to possible redemption (3,928,774 ) Accretion to redemption value 314,307 Class A common stock subject to possible redemption $ 49,242,796 |
Schedule of Fair Value Assets And Liabilities | The Company determined the fair value of the over-allotment liability on March 31, 2023 was $ , using the Bla ck March 31, Risk-free interest rate 4.77 % Expected option life 0.099 years Expected dividend yield 0 % Expected stock price volatility 5 % |
Organization and Description _2
Organization and Description of Business - Additional Information (Detail) - USD ($) | 1 Months Ended | 3 Months Ended | ||||
Mar. 17, 2023 | Mar. 17, 2023 | Mar. 16, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | Dec. 31, 2022 | |
Organization And Description Of Business [Line Items] | ||||||
Proceeds from issuance of common stock | $ 54,210,000 | $ 0 | $ 54,210,000 | |||
Deferred underwriting fees payable noncurrent | $ 2,710,500 | |||||
Payments to acquire restricted investments | $ 0 | 55,836,300 | ||||
Transaction costs | 4,019,087 | |||||
Payment of deferred underwriting fees | 813,150 | |||||
Other offering costs | 1,038,067 | |||||
Cash | $ 974,028 | 285,320 | $ 1,280 | |||
Term of restricted investments | 185 days | |||||
Minimum net worth to consummate business combination | $ 5,000,001 | |||||
Percentage of shares that can be transferred without restriction | 15% | |||||
Percentage of public shares to be redeemed on non completion of business combination | 100% | |||||
Combination Period | 12 months | |||||
Per share value of restricted assets per extension | $ 0.1 | |||||
Per share value of restricted assets | $ 0.2 | |||||
Extended business combination period | 18 months | |||||
Expenses payable on dissolution | $ 100,000 | |||||
Per share amount to be maintained in the trust account | $ 10.3 | |||||
Proceeds from sale of restricted investments | $ 0 | |||||
Share price | $ 0.81 | |||||
Inflation Reduction Act of Two Thousand And Twenty Two [Member] | ||||||
Organization And Description Of Business [Line Items] | ||||||
Percentage of excise tax rate on certain share repurchases | 1% | |||||
Percentage of excise tax rate of fair market value of share repurchases | 1% | |||||
Minimum [Member] | ||||||
Organization And Description Of Business [Line Items] | ||||||
Prospective assets of acquire as a percentage of fair value of assets in the trust account | 80% | |||||
Percentage of voting securities acquired | 50% | |||||
Sponsor [Member] | Working Capital Loans [Member] | ||||||
Organization And Description Of Business [Line Items] | ||||||
Bank overdrafts | $ 0 | |||||
IPO [Member] | ||||||
Organization And Description Of Business [Line Items] | ||||||
Stock issued during period shares | 5,200,000 | |||||
Common stock, par or stated value per share | $ 0.0001 | |||||
Sale of stock, price per share | 10 | |||||
Payments to acquire restricted investments | $ 55,836,300 | |||||
Shares issued price per share | 10 | $ 10 | ||||
Share price | $ 10.3 | |||||
Over-Allotment Option [Member] | ||||||
Organization And Description Of Business [Line Items] | ||||||
Stock issued during period shares | 221,000 | |||||
Over-Allotment Option [Member] | Underwriting Agreement [Member] | ||||||
Organization And Description Of Business [Line Items] | ||||||
Stock issued during period shares | 221,000 | |||||
Public Warrants [Member] | IPO [Member] | ||||||
Organization And Description Of Business [Line Items] | ||||||
Number of warrants issued per unit | 1 | |||||
Class of warrant or right, number of securities called by each warrant or right | 1 | |||||
Class of warrants or rights exercise price per share | $ 11.5 | |||||
Public Warrants [Member] | Over-Allotment Option [Member] | ||||||
Organization And Description Of Business [Line Items] | ||||||
Stock issued during period shares | 780,000 | |||||
Private Placement Warrants [Member] | ||||||
Organization And Description Of Business [Line Items] | ||||||
Class of warrant or right, number of securities called by each warrant or right | 1 | |||||
Private Placement Warrants [Member] | Sponsor [Member] | ||||||
Organization And Description Of Business [Line Items] | ||||||
Class of warrants or rights exercise price per share | $ 1 | |||||
Class of warrants or rights issue of warrants during the period | 3,576,900 | |||||
Private Placement Warrants [Member] | Private Placement [Member] | Sponsor [Member] | ||||||
Organization And Description Of Business [Line Items] | ||||||
Proceeds from sale of private placement warrants | $ 3,577,000 | |||||
Common Class A [Member] | ||||||
Organization And Description Of Business [Line Items] | ||||||
Common stock, par or stated value per share | $ 0.0001 | $ 0.0001 | ||||
Proceeds from issuance of common stock | $ 54,210,000 | |||||
Common Class A [Member] | IPO [Member] | ||||||
Organization And Description Of Business [Line Items] | ||||||
Stock issued during period shares | 5,200,000 | |||||
Number of shares issued per unit | 1 | |||||
Class of warrant or right, number of securities called by each warrant or right | 1 | 1 | ||||
Class of warrants or rights exercise price per share | $ 11.5 | $ 11.5 | ||||
Common Class A [Member] | IPO [Member] | Representative Shares [Member] | Underwriting Agreement [Member] | ||||||
Organization And Description Of Business [Line Items] | ||||||
Stock issued during period shares | 54,210 | |||||
Common Class A [Member] | Over-Allotment Option [Member] | Representative Shares [Member] | Underwriting Agreement [Member] | ||||||
Organization And Description Of Business [Line Items] | ||||||
Stock issued during period shares | 52,000 | |||||
Equity, fair value disclosure | $ 270,520 |
Summary Of Significant Accoun_4
Summary Of Significant Accounting Policies - Schedule Of Stock By Class (Detail) | 3 Months Ended | |
Mar. 31, 2023 USD ($) $ / shares shares | ||
Class A Common Stock Subject To Possible Redemption [Member] | ||
Class of Stock [Line Items] | ||
Allocation of undistributable losses | $ | $ (34,186) | |
Weighted average shares outstanding, basic | shares | 5,421,000 | |
Weighted average shares outstanding, diluted | shares | 5,421,000 | |
Basic net loss per share | $ / shares | $ (0.01) | |
Diluted net loss per share | $ / shares | $ (0.01) | |
Common Class A [Member] | ||
Class of Stock [Line Items] | ||
Allocation of undistributable losses | $ | $ (342) | |
Weighted average shares outstanding, basic | shares | 54,210 | |
Weighted average shares outstanding, diluted | shares | 54,210 | |
Basic net loss per share | $ / shares | $ (0.01) | |
Diluted net loss per share | $ / shares | $ (0.01) | |
Common Class B [Member] | ||
Class of Stock [Line Items] | ||
Allocation of undistributable losses | $ | $ (8,256) | |
Weighted average shares outstanding, basic | shares | 1,309,208 | [1] |
Weighted average shares outstanding, diluted | shares | 1,309,208 | [1] |
Basic net loss per share | $ / shares | $ (0.01) | |
Diluted net loss per share | $ / shares | $ (0.01) | |
[1]Excludes up to 139,750 shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 5 and 7). |
Summary Of Significant Accoun_5
Summary Of Significant Accounting Policies - Schedule Of Temporary Equity By Class Of Stock (Detail) - USD ($) | 1 Months Ended | 3 Months Ended | ||
Mar. 17, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | Dec. 31, 2022 | |
Temporary Equity [Line Items] | ||||
Gross proceeds from sale of Public Units | $ 54,210,000 | $ 0 | $ 54,210,000 | |
Less: Proceeds allocated to Public Warrants | $ 0 | (3,577,000) | ||
Accretion to redemption value | (314,307) | |||
Class A common stock subject to possible redemption | 49,242,796 | $ 0 | ||
Common Class A [Member] | ||||
Temporary Equity [Line Items] | ||||
Gross proceeds from sale of Public Units | 54,210,000 | |||
Less: Proceeds allocated to Public Warrants | (1,218,153) | |||
Less: Proceeds allocated to underwriters' over-allotment option | (134,584) | |||
Less: Issuance costs allocated to Class A common stock subject to possible redemption | 3,928,774 | |||
Accretion to redemption value | (314,307) | |||
Class A common stock subject to possible redemption | $ 49,242,796 |
Summary Of Significant Accoun_6
Summary Of Significant Accounting Policies - Schedule of Fair Value Assets And Liabilities (Detail) - Over-Allotment Option [Member] | Mar. 31, 2023 yr |
Risk-free interest rate [Member] | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Derivative Liability, Measurement Input | 4.77 |
Expected option life [Member] | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Derivative Liability, Measurement Input | 0.099 |
Expected dividend yield [Member] | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Derivative Liability, Measurement Input | 0 |
Expected stock price volatility [Member] | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Derivative Liability, Measurement Input | 5 |
Summary Of Significant Accoun_7
Summary Of Significant Accounting Policies - Additional Information (Detail) | 3 Months Ended | |
Mar. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | |
Summary Of Significant Accounting Policies [Line Items] | ||
Proceeds from trust account to pay tax obligations | $ 0 | |
FDIC limit | 250,000 | |
Liquidation basis of accounting, accrued costs to dispose of assets and liabilities | 100,000 | |
Due from sponsor | $ 27,820 | $ 2,820 |
Public Warrants [Member] | Measurement Input, Probability Of Completing A Successful Business Combination [Member] | ||
Summary Of Significant Accounting Policies [Line Items] | ||
Warrants and Rights Outstanding, Measurement Input | 50 | |
Representative Shares [Member] | Measurement Input, Probability Of Consummation Of The Business Combination And A Discount For Lack Of Marketability [Member] | ||
Summary Of Significant Accounting Policies [Line Items] | ||
Derivative Liability, Measurement Input | 50 | |
Sponsor [Member] | ||
Summary Of Significant Accounting Policies [Line Items] | ||
Related party transaction, amounts of transaction | $ 25,000 | |
Costs and expenses, related party | 2,820 | |
Over-Allotment Option [Member] | ||
Summary Of Significant Accounting Policies [Line Items] | ||
Fair vlaue of overallotment liability | 173,764 | |
Change in fair value of overallotment option | 39,181 | |
Class A Common Stock Subject To Possible Redemption [Member] | ||
Summary Of Significant Accounting Policies [Line Items] | ||
Liquidation basis of accounting, accrued costs to dispose of assets and liabilities | 100,000 | |
Maximum net interests to pay dissolution expenses | $ 100,000 |
Initial Public Offering - Addit
Initial Public Offering - Additional Information (Detail) - USD ($) | 1 Months Ended | 3 Months Ended | |||
Mar. 17, 2023 | Mar. 17, 2023 | Mar. 16, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | |
Class of Stock [Line Items] | |||||
Proceeds from Issuance of Common Stock | $ 54,210,000 | $ 0 | $ 54,210,000 | ||
IPO [Member] | |||||
Class of Stock [Line Items] | |||||
Stock Issued During Period, Shares, New Issues | 5,200,000 | ||||
Shares issued price per share | $ 10 | $ 10 | |||
IPO [Member] | Public Warrants [Member] | |||||
Class of Stock [Line Items] | |||||
Number of securities called by each warrant or right | 1 | ||||
Class of warrants or rights exercise price per share | $ 11.5 | ||||
Over-Allotment Option [Member] | |||||
Class of Stock [Line Items] | |||||
Stock Issued During Period, Shares, New Issues | 221,000 | ||||
Over-Allotment Option [Member] | Underwriters Agreement [Member] | |||||
Class of Stock [Line Items] | |||||
Stock Issued During Period, Shares, New Issues | 221,000 | ||||
Proceeds from Issuance of Common Stock | $ 2,210,000 | ||||
Share Based Compensation Overallotment Options Expiration | 559,000 | ||||
Over-Allotment Option [Member] | Public Warrants [Member] | |||||
Class of Stock [Line Items] | |||||
Stock Issued During Period, Shares, New Issues | 780,000 |
Private Placement - Additional
Private Placement - Additional Information (Detail) - USD ($) | 1 Months Ended | 3 Months Ended | ||
Mar. 17, 2023 | Mar. 16, 2023 | Mar. 31, 2022 | Mar. 31, 2023 | |
Disclosure of Private Placement [Line Items] | ||||
Proceeds from sale of Warrants | $ 0 | $ 3,577,000 | ||
Sponsor [Member] | Private Placement Warrants [Member] | ||||
Disclosure of Private Placement [Line Items] | ||||
Class of warrant or right issued during the period | 3,449,500 | |||
Price of warrant | $ 1 | |||
Proceeds from sale of Warrants | $ 3,449,500 | |||
Over-Allotment Option [Member] | Private Placement Warrants [Member] | ||||
Disclosure of Private Placement [Line Items] | ||||
Class of warrant or right issued during the period | 127,400 | 127,400 | ||
Proceeds from sale of Warrants | $ 127,500 |
Related Party Transactions - Ad
Related Party Transactions - Additional Information (Detail) - USD ($) | 1 Months Ended | 3 Months Ended | ||||||||||
Apr. 30, 2023 | Mar. 22, 2023 | Mar. 17, 2023 | Mar. 16, 2023 | Aug. 26, 2022 | May 10, 2022 | May 01, 2022 | Mar. 31, 2022 | Mar. 31, 2023 | Dec. 31, 2023 | Feb. 28, 2023 | Dec. 31, 2022 | |
Related Party Transaction [Line Items] | ||||||||||||
Share price | $ 0.81 | |||||||||||
Proceeds from sale of Warrants | $ 0 | $ 3,577,000 | ||||||||||
Due from related parties | $ 27,820 | |||||||||||
Private Placement Warrants [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Number of securities called by each warrant or right | 1 | |||||||||||
Over-Allotment Option [Member] | Private Placement Warrants [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Class of warrant or right issued during the period | 127,400 | 127,400 | ||||||||||
Proceeds from sale of Warrants | $ 127,500 | |||||||||||
Subsequent Event [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Due from related parties | $ 2,820 | |||||||||||
Subsequent Event [Member] | Over-Allotment Option [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Number of shares forfeited during the period | 139,750 | |||||||||||
Common Class B [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Common stock, par value | $ 0.0001 | $ 0.0001 | ||||||||||
Common stock, shares outstanding | 1,495,000 | 1,495,000 | ||||||||||
Sponsor [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Related party transaction fees payable per month | $ 25,000 | |||||||||||
Sponsor [Member] | Private Placement Warrants [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Class of warrant or right issued during the period | 3,449,500 | |||||||||||
Price of warrant | $ 1 | |||||||||||
Proceeds from sale of Warrants | $ 3,449,500 | |||||||||||
Sponsor [Member] | Administration and Support Services [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Related party transaction fees payable per month | $ 10,000 | |||||||||||
Sponsor [Member] | Commercial Paper [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Maximum borrowing capacity under the credit facility | 440,000 | $ 400,000 | ||||||||||
Line of credit facility additional borrowing capacity | 40,000 | |||||||||||
Sponsor [Member] | Working Capital Loans [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Maximum borrowing capacity under the credit facility | 2,000,000 | |||||||||||
Working capital loans convertible into equity warrants | $ 2,000,000 | |||||||||||
Debt instrument conversion price per share | $ 1 | |||||||||||
Bank overdrafts | $ 0 | |||||||||||
Sponsor [Member] | Common Class B [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Stock shares issued during the period for services value | $ 25,000 | |||||||||||
Share price | $ 0.011 | |||||||||||
Stock shares issued during the period for services shares | 2,156,250 | |||||||||||
Common stock, par value | $ 0.0001 | |||||||||||
Stock Surrendered During Period, Shares | 287,500 | |||||||||||
Stock Surrendered During Period, Value | $ 0 | |||||||||||
Common stock, shares outstanding | 1,495,000 | 1,868,750 | ||||||||||
Number of shares forfeited during the period | 55,250 | 373,750 | ||||||||||
Value of forfeited shares issued under share-based payment arrangement | $ 0 | |||||||||||
Common stock subject to forfeiture | 139,750 | 195,000 | ||||||||||
Sponsor [Member] | Common Class B [Member] | Subsequent Event [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Number of shares forfeited during the period | 139,750 | |||||||||||
Sponsor [Member] | Common Class B [Member] | Rahul Mewawalla [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Number of shares issued by sponsor | 25,000 | |||||||||||
Sponsor [Member] | Common Class B [Member] | Stephen Markscheid [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Number of shares issued by sponsor | 25,000 |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Detail) - USD ($) | Apr. 30, 2023 | Mar. 17, 2023 | Mar. 16, 2023 | Mar. 31, 2023 |
Underwriting Agreement [Member] | Representative Shares [Member] | ||||
Other Commitments [Line Items] | ||||
Shares issued under share-based payment arrangement | 52,000 | |||
Underwriting Agreement [Member] | Business Combination Event [Member] | ||||
Other Commitments [Line Items] | ||||
Deferred underwriting commission per share | $ 0.35 | |||
Deferred underwriting commission | $ 1,897,350 | |||
Over-Allotment Option [Member] | ||||
Other Commitments [Line Items] | ||||
Over allotment option period | $ 45 | |||
Common stock shares subscribed but not issued | 780,000 | |||
Stock issued during the period shares | 221,000 | |||
Over-Allotment Option [Member] | Underwriting Agreement [Member] | ||||
Other Commitments [Line Items] | ||||
Stock issued during the period shares | 221,000 | |||
Over-Allotment Option [Member] | Subsequent Event [Member] | ||||
Other Commitments [Line Items] | ||||
Stock forfeitured during period shares | 559,000 | |||
IPO [Member] | ||||
Other Commitments [Line Items] | ||||
Stock issued during the period shares | 5,200,000 | |||
IPO [Member] | Underwriting Agreement [Member] | ||||
Other Commitments [Line Items] | ||||
Deferred underwriting commission per share | $ 0.15 | |||
Deferred underwriting commission | $ 813,150 |
Stockholders' Equity - Addition
Stockholders' Equity - Additional Information (Detail) - USD ($) | 3 Months Ended | ||
Mar. 31, 2023 | Mar. 16, 2023 | Dec. 31, 2022 | |
Stockholders equity [Line Items] | |||
Preferred Stock, Par or Stated Value Per Share | $ 0.0001 | $ 0.0001 | |
Preferred stock, shares authorized | 5,000,000 | 5,000,000 | |
Preferred stock, shares issued | 0 | 0 | |
Preferred stock, shares outstanding | 0 | 0 | |
Percentage of common stock on conversion of shares | 20% | ||
Share price | $ 0.81 | ||
IPO [Member] | |||
Stockholders equity [Line Items] | |||
Common stock par or stated value per share | $ 0.0001 | ||
Share price | $ 10.3 | ||
Public Warrants [Member] | |||
Stockholders equity [Line Items] | |||
Warrants and rights outstanding | $ 5,421,000 | $ 0 | |
Warrants and rights outstanding term | 5 years | ||
Class Of Warrants Or Rights Redemption Price Per Unit | $ 0.01 | ||
Notice period to be given prior to redemption | 30 days | ||
Public Warrants [Member] | From The Completion Of Business Combination [Member] | |||
Stockholders equity [Line Items] | |||
Class of warrants or rights period after which the warrants are exercisable | 30 days | ||
Public Warrants [Member] | IPO [Member] | |||
Stockholders equity [Line Items] | |||
Number of securities called by each warrant or right | 1 | ||
Class of warrants or rights exercise price per share | $ 11.5 | ||
Private Placement Warrants [Member] | |||
Stockholders equity [Line Items] | |||
Warrants and rights outstanding | $ 3,576,900 | $ 0 | |
Number of securities called by each warrant or right | 1 | ||
Common Class A [Member] | |||
Stockholders equity [Line Items] | |||
Common stock, shares authorized | 26,000,000 | 26,000,000 | |
Common stock par or stated value per share | $ 0.0001 | $ 0.0001 | |
Common stock, voting rights | one vote for each share | ||
Common stock, shares, issued | 54,210 | 0 | |
Common stock, shares, outstanding | 54,210 | 0 | |
Common stock, shares, issued | 5,421,000 | ||
Common stock, shares, outstanding | 5,421,000 | ||
Number of trading days for determining the average reported last sale price | 10 days | ||
Common Class A [Member] | IPO [Member] | |||
Stockholders equity [Line Items] | |||
Number of securities called by each warrant or right | 1 | 1 | |
Class of warrants or rights exercise price per share | $ 11.5 | $ 11.5 | |
Common Class A [Member] | Public Warrants [Member] | |||
Stockholders equity [Line Items] | |||
Exercise Price Of Warrants Percentage | 115% | ||
Common Class A [Member] | Public Warrants [Member] | Share Price Equal Or Less Nine Point Two Rupees Per Dollar [Member] | |||
Stockholders equity [Line Items] | |||
Share price | $ 9.2 | ||
Proceeds used for business combination as a percentage of total equity proceeds | 60% | ||
Volume weighted average price of shares | $ 9.2 | ||
Common Class A [Member] | Public Warrants [Member] | Share Price Equal Or Exceeds Eighteen Rupees Per Dollar [Member] | |||
Stockholders equity [Line Items] | |||
Share price | $ 18 | ||
Exercise Price Of Warrants Percentage | 180% | ||
Share Redemption Trigger Price | $ 18 | ||
Number Of trading days for determining the share price | 20 days | ||
Number of consecutive trading days for determining the share price | 30 days | ||
Common Class B [Member] | |||
Stockholders equity [Line Items] | |||
Common stock, shares authorized | 4,000,000 | 4,000,000 | |
Common stock par or stated value per share | $ 0.0001 | $ 0.0001 | |
Common stock, voting rights | one vote for each share | ||
Common stock, shares, issued | 1,495,000 | 1,495,000 | |
Common stock, shares, outstanding | 1,495,000 | 1,495,000 | |
Stock conversion basis | one-to-one |
Stock-Based Compensation - Addi
Stock-Based Compensation - Additional Information (Detail) - USD ($) | 1 Months Ended | 13 Months Ended | ||||
Mar. 17, 2023 | Mar. 17, 2023 | Mar. 16, 2023 | Aug. 31, 2022 | Mar. 31, 2023 | May 01, 2022 | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||
Compensation expense | $ 0 | |||||
Share price | $ 0.81 | |||||
Aggregate grant date fair value of the awards | $ 40,500 | |||||
Unrecognized compensation expense | $ 40,500 | |||||
Over-Allotment Option [Member] | ||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||
Stock issued during the period shares | 221,000 | |||||
Over-Allotment Option [Member] | Underwriting Agreement [Member] | ||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||
Stock issued during the period shares | 221,000 | |||||
Representative Shares [Member] | Underwriting Agreement [Member] | ||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||
Shares issued under share-based payment arrangement | 54,210 | |||||
Fair value of shares issued under share-based payment arrangement | $ 270,520 | |||||
Representative Shares [Member] | Over-Allotment Option [Member] | ||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||
Shares Issued | 2,210 | 2,210 | ||||
Total Shares | 54,210 | 54,210 | ||||
Common Class A [Member] | Representative Shares [Member] | Over-Allotment Option [Member] | Underwriting Agreement [Member] | ||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||
Stock issued during the period shares | 52,000 | |||||
Common Class B [Member] | Sponsor [Member] | ||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||
Share price | $ 0.011 | |||||
Common Class B [Member] | Director [Member] | Sponsor [Member] | ||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||
Sponsor transferred share | 25,000 |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Detail) | 1 Months Ended | 3 Months Ended |
Mar. 31, 2022 | Mar. 31, 2023 | |
Income Tax Disclosure [Abstract] | ||
Effective tax rate | 0% | 19.70% |
Statutory rate | 21% | 21% |
Subsequent Events - Additional
Subsequent Events - Additional Information (Detail) - USD ($) | Jun. 29, 2023 | Apr. 30, 2023 | Apr. 28, 2023 |
Subsequent Event [Line Items] | |||
Paid to unauthorized payee monetary | $ 54,300 | ||
Recovered from unauthorized payee | $ 54,300 | ||
Subsequent Event [Member] | Over-Allotment Option [Member] | |||
Subsequent Event [Line Items] | |||
Overallotment option units expired | 559,000 | ||
Shares forfeited during the period, shares | 139,750 |